The Food Safety and Standards Authority of India (FSSAI) suspends the licence of Dior Pharmaceuticals following an inspection of its nutraceutical manufacturing unit in Punjab. According to FSSAI, inspectors observed “serious non-compliances” and “major and critical non-conformities” at the facility. These issues are reported to violate the provisions of the Food Safety and Standards Act, 2006. The action follows the agency’s assessment of manufacturing and compliance conditions at the plant during the inspection. The sources indicate that FSSAI’s decision is based on the findings recorded during the visit, rather than on consumer complaints or product testing results. No additional details about the specific violations or the duration of the suspension are provided in the available reports. The suspension underscores FSSAI’s role in enforcing food safety regulations through inspections of licensed manufacturing units, especially those producing nutraceutical products.